GILD

What Happened to Gilead Sciences and Is the Stock Still a Buy?

Gilead stock has been under pressure for a few months, giving investors a great risk/reward setup, especially with its coronavirus treatment.

Remdesivir Data Leaves Gilead Stock Well-Positioned to Rally

Strong sales of Gilead's successful novel coronavirus drug, remdesivir, will ultimately lift GILD stock and reward shareholders.

30 Dividend Stocks to Buy Now for 20 Years of Income Growth

With a 20-year timeline, you have multiple choices for dividend stocks to buy. Here are 30 names that should do very well.

4 Coronavirus Stocks to Buy as the Pandemic Rages On

As the pandemic continues to grow, these four coronavirus stocks are great ways to protect your portfolio for the foreseeable future.

Quick Income from a Put Write on Johnson & Johnson

Earnings season is upon us, and Johnson & Johnson (NYSE:JNJ) will kick off second-quarter reporting for the big pharmaceutical stocks on July 16.

4 Pharmaceutical Stocks to Watch for the Rest of 2020

As pharmaceutical companies rush to manufacture coronavirus vaccine and drugs, it makes sense to hold some potential winners.

10 Stocks Riding on the Covid-19 Recovery

With pandemic fears shuttering many economies, most investments have cratered. However, a small group of coronavirus stocks may offer significant upside potential.

7 Cash Stocks to Invest in As Markets Turn Negative

Consider these seven cash stocks (both defensive and cyclical) as strong buys with upside relative to risk, as markets continue to yo-yo.

Gilead Gets a Boost From Positive Coronavirus Research

Signs continue to mount that remdesivir is a highly effective treatment for the coronavirus. The drug will move the needle for GILD stock.

Remdesivir Can’t Cure Covid, But Good Luck Telling Gilead Stock

Gilead is moving into commercial production of Remdesivir, a COVID-19 treatment with an aggressive pricing model, but other biotech solutions could come out ahead; it's early days still.

Gilead Stock Is Worth Owning With or Without a Coronavirus Cure

GILD stock has been rallying, but it has been running out of momentum lately. Just don't lose focus on the positives for Gilead.

Stock Market Today: Coronavirus Treatments Make Progress; Nvidia to $425?

Nvidia caught a huge price target increase, while Apple looks to reopen its stores. Here's what happened in the stock market today.

Buy Good News Gilead Stock Before Other Investors Catch On

Positive signs continue to mount for remdesivir, yet the market continues to have mixed feelings about GILD stock.

Gilead Stock Still Looks Poised to Prove the Bears Wrong

With remdesivir poised to become a blockbuster drug for Gilead, GILD stock still looks poised to prove the bears wrong

9 Enduring Stocks That You Shouldn’t Sell in May

Under any other circumstance, sell in May and go away may be considered a sound strategy. In this crisis, though, you may want to keep these stocks to buy for the long haul.

Stock Market Today: Carnival Bookings Surge; Chesapeake on the Brink

Could the S&P 500 be heading for 3,000? Plus, Chesapeake Energy is on the brink. Here's what else happened in the stock market today.

Gilead Sciences Is a Strong Buy Despite What Its Detractors Might Say

Gilead Sciences is donating 1.5 million doses of remdesivir, which has many analysts bullish on GILD stock now.

Despite Gains, Threat, Gilead Is Still Attractive

GILD stock gets a boost from remdesivir, which has been approved as an emergency treatment for the coronavirus, Gilead still faces a threat.

Sell a Put on Capital One for Incredible Income

With some countries and states moving to reopen businesses, Capital One Financial Corporation (NYSE:COF) is an excellent target for a bullish put write.